Literature DB >> 27984255

Knowns and Unknowns About Delirium in Stroke: A Review.

Elzbieta Klimiec1, Tomasz Dziedzic, Katarzyna Kowalska, Agnieszka Slowik, Aleksandra Klimkowicz-Mrowiec.   

Abstract

Delirium is a transient condition characterized by sudden and fluctuating disturbances in cognitive function. The condition can be considered a sign of the brain's vulnerability and diminished resilience to insult. Among the many clinical manifestations are cognitive, psychomotor, and sleep disturbances. Delirium is associated with longer hospital stays, worse functional outcomes, and higher mortality. Although up to 48% of patients who have had a stroke develop delirium, the condition has been studied much less in these patients than in general medicine, surgical, and intensive care patients. Coexisting neurologic deficits in patients with stroke limit the use of screening tools that are widely accepted in other populations. The variability of reported assessment methods highlights the need for delirium screening guidelines in stroke. Further, risk factors that are specific to stroke may play an important role in the etiology of delirium, along with such well-known factors as older age and infections. The delirium literature lacks data on differences in clinical manifestations and course in the various types of stroke. Here we review predisposing factors, diagnostic methods, and biomarkers of delirium in stroke and discuss aspects that need further research.

Entities:  

Mesh:

Year:  2016        PMID: 27984255     DOI: 10.1097/WNN.0000000000000110

Source DB:  PubMed          Journal:  Cogn Behav Neurol        ISSN: 1543-3633            Impact factor:   1.600


  8 in total

1.  Delirium Monitoring in Neurocritically Ill Patients: A Systematic Review.

Authors:  Mayur B Patel; Josef Bednarik; Patricia Lee; Yahya Shehabi; Jorge I Salluh; Arjen J Slooter; Kate E Klein; Yoanna Skrobik; Alessandro Morandi; Peter E Spronk; Andrew M Naidech; Brenda T Pun; Fernando A Bozza; Annachiara Marra; Sayona John; Pratik P Pandharipande; E Wesley Ely
Journal:  Crit Care Med       Date:  2018-11       Impact factor: 7.598

2.  Night-time confusion in an elderly woman post-stroke.

Authors:  M Christien van der Linden; Ido R van den Wijngaard; Shanna van der Linden; Naomi van der Linden
Journal:  BMJ Case Rep       Date:  2020-05-21

3.  Pre-stroke apathy symptoms are associated with an increased risk of delirium in stroke patients.

Authors:  Elzbieta Klimiec; Katarzyna Kowalska; Paulina Pasinska; Aleksandra Klimkowicz-Mrowiec; Aleksandra Szyper; Joanna Pera; Agnieszka Slowik; Tomasz Dziedzic
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

4.  Reduced ex vivo release of pro-inflammatory cytokines and elevated plasma interleukin-6 are inflammatory signatures of post-stroke delirium.

Authors:  Katarzyna Kowalska; Elzbieta Klimiec; Kazimierz Weglarczyk; Joanna Pera; Agnieszka Slowik; Maciej Siedlar; Tomasz Dziedzic
Journal:  J Neuroinflammation       Date:  2018-04-18       Impact factor: 8.322

5.  Outcome Differences by Delirium Motor Subtype in Patients with Ischemic Stroke.

Authors:  Hee Won Yang; Miji Lee; Jong Wook Shin; Hye Seon Jeong; Jei Kim; Jeong Lan Kim
Journal:  Psychiatry Investig       Date:  2019-10-28       Impact factor: 2.505

Review 6.  Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19.

Authors:  Dipak Kumar; Sadaf Jahan; Andleeb Khan; Arif Jamal Siddiqui; Neeru Singh Redhu; Johra Khan; Saeed Banwas; Bader Alshehri; Mohammed Alaidarous
Journal:  Mol Neurobiol       Date:  2021-03-14       Impact factor: 5.590

7.  Association of early and later depressive symptoms with functional outcome after ischemic stroke.

Authors:  Anna Maria Lopatkiewicz; Joanna Pera; Agnieszka Slowik; Tomasz Dziedzic
Journal:  J Neural Transm (Vienna)       Date:  2021-03-16       Impact factor: 3.575

8.  Delirium and subsyndromal delirium are associated with the long-term risk of death after ischaemic stroke.

Authors:  Elzbieta Klimiec-Moskal; Agnieszka Slowik; Tomasz Dziedzic
Journal:  Aging Clin Exp Res       Date:  2022-01-11       Impact factor: 4.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.